245 related articles for article (PubMed ID: 18587053)
1. The Fas system confers protection against alveolar disruption in hyperoxia-exposed newborn mice.
Mao Q; Gundavarapu S; Patel C; Tsai A; Luks FI; De Paepe ME
Am J Respir Cell Mol Biol; 2008 Dec; 39(6):717-29. PubMed ID: 18587053
[TBL] [Abstract][Full Text] [Related]
2. Hyperoxia-induced apoptosis and Fas/FasL expression in lung epithelial cells.
De Paepe ME; Mao Q; Chao Y; Powell JL; Rubin LP; Sharma S
Am J Physiol Lung Cell Mol Physiol; 2005 Oct; 289(4):L647-59. PubMed ID: 16148053
[TBL] [Abstract][Full Text] [Related]
3. Critical roles of inflammation and apoptosis in improved survival in a model of hyperoxia-induced acute lung injury in Pneumocystis murina-infected mice.
Beck JM; Preston AM; Wilcoxen SE; Morris SB; Sturrock A; Paine R
Infect Immun; 2009 Mar; 77(3):1053-60. PubMed ID: 19124601
[TBL] [Abstract][Full Text] [Related]
4. Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis.
Tateda K; Deng JC; Moore TA; Newstead MW; Paine R; Kobayashi N; Yamaguchi K; Standiford TJ
J Immunol; 2003 Apr; 170(8):4209-16. PubMed ID: 12682254
[TBL] [Abstract][Full Text] [Related]
5. Fas/FasL-mediated apoptosis in perinatal murine lungs.
De Paepe ME; Mao Q; Embree-Ku M; Rubin LP; Luks FI
Am J Physiol Lung Cell Mol Physiol; 2004 Oct; 287(4):L730-42. PubMed ID: 15355863
[TBL] [Abstract][Full Text] [Related]
6. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
Djamali A; Odorico JS
Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
[TBL] [Abstract][Full Text] [Related]
7. Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury.
Paine R; Wilcoxen SE; Morris SB; Sartori C; Baleeiro CE; Matthay MA; Christensen PJ
Am J Pathol; 2003 Dec; 163(6):2397-406. PubMed ID: 14633611
[TBL] [Abstract][Full Text] [Related]
8. Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers.
Li XK; Fujino M; Sugioka A; Morita M; Okuyama T; Guo L; Funeshima N; Kimura H; Enosawa S; Amemiya H; Suzuki S
Transplantation; 2001 Feb; 71(4):503-8. PubMed ID: 11258428
[TBL] [Abstract][Full Text] [Related]
9. Increased retinal neovascularization in Fas ligand-deficient mice.
Davies MH; Eubanks JP; Powers MR
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3202-10. PubMed ID: 12824272
[TBL] [Abstract][Full Text] [Related]
10. Fas activation alters tight junction proteins in acute lung injury.
Herrero R; Prados L; Ferruelo A; Puig F; Pandolfi R; Guillamat-Prats R; Moreno L; Matute-Bello G; Artigas A; Esteban A; Lorente JÁ
Thorax; 2019 Jan; 74(1):69-82. PubMed ID: 30385692
[No Abstract] [Full Text] [Related]
11. Oxygen toxicity in mouse lung: pathways to cell death.
Barazzone C; Horowitz S; Donati YR; Rodriguez I; Piguet PF
Am J Respir Cell Mol Biol; 1998 Oct; 19(4):573-81. PubMed ID: 9761753
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand is required for resolution of granulomatous experimental autoimmune thyroiditis.
Wei Y; Chen K; Sharp GC; Braley-Mullen H
J Immunol; 2004 Dec; 173(12):7615-21. PubMed ID: 15585889
[TBL] [Abstract][Full Text] [Related]
13. HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway.
Krzyzowska M; Baska P; Orlowski P; Zdanowski R; Winnicka A; Eriksson K; Stankiewicz W
PLoS One; 2013; 8(7):e70308. PubMed ID: 23922974
[TBL] [Abstract][Full Text] [Related]
14. The Fas/FasL pathway impairs the alveolar fluid clearance in mouse lungs.
Herrero R; Tanino M; Smith LS; Kajikawa O; Wong VA; Mongovin S; Matute-Bello G; Martin TR
Am J Physiol Lung Cell Mol Physiol; 2013 Sep; 305(5):L377-88. PubMed ID: 23812636
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.
Omokaro SO; Desierto MJ; Eckhaus MA; Ellison FM; Chen J; Young NS
J Immunol; 2009 Mar; 182(6):3414-22. PubMed ID: 19265119
[TBL] [Abstract][Full Text] [Related]
16. Alveolar epithelial type II cell apoptosis in vivo during resolution of keratinocyte growth factor-induced hyperplasia in the rat.
Fehrenbach H; Kasper M; Koslowski R; Pan T; Schuh D; Müller M; Mason RJ
Histochem Cell Biol; 2000 Jul; 114(1):49-61. PubMed ID: 10959822
[TBL] [Abstract][Full Text] [Related]
17. Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria.
Matute-Bello G; Frevert CW; Liles WC; Nakamura M; Ruzinski JT; Ballman K; Wong VA; Vathanaprida C; Martin TR
Infect Immun; 2001 Sep; 69(9):5768-76. PubMed ID: 11500454
[TBL] [Abstract][Full Text] [Related]
18. Pathogen-associated molecular patterns sensitize macrophages to Fas ligand-induced apoptosis and IL-1 beta release.
Fukui M; Imamura R; Umemura M; Kawabe T; Suda T
J Immunol; 2003 Aug; 171(4):1868-74. PubMed ID: 12902488
[TBL] [Abstract][Full Text] [Related]
19. Neonatal periostin knockout mice are protected from hyperoxia-induced alveolar simplication.
Bozyk PD; Bentley JK; Popova AP; Anyanwu AC; Linn MD; Goldsmith AM; Pryhuber GS; Moore BB; Hershenson MB
PLoS One; 2012; 7(2):e31336. PubMed ID: 22363622
[TBL] [Abstract][Full Text] [Related]
20. Fas-ligand-induced apoptosis of respiratory epithelial cells causes disruption of postcanalicular alveolar development.
De Paepe ME; Gundavarapu S; Tantravahi U; Pepperell JR; Haley SA; Luks FI; Mao Q
Am J Pathol; 2008 Jul; 173(1):42-56. PubMed ID: 18535181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
